BOSTON and YOKNEAM, Israel, May 3, 2024 /PRNewswire/ Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited
ImmunoPrecise Antibodies (NASDAQ: IPA) (“IPA”), a leading company in AI-driven biotherapeutic research and technology, has recently announced important changes to its Board of Directors and upcoming financial reporting activities.
ImmunoPrecise Antibodies Ltd. , a leader in AI-driven biotherapeutic research and technology, is pleased to announce important Board of Director changes and upcoming financial reporting.